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1. Introduction
Gastric malignant tumors re-
main the most common form of 
malignancy in many countries in 
Europe, Asia and South America. 
The highest incidence is observed 
in Japan – 91.4 per 100 thousand 
population per year, and the 
lowest is registered in the Unit-
ed States – 6.9 per 100 thousand 
population per year [1]. Ukraine 
is one of the countries with an 
average incidence of gastric can- 
cer – 30.8 per 100 thousand pop-
ulation per year [2, 3]. Despite 
advances in the diagnosis of ma-
lignant tumors, the number of 
patients with stage III–IV gastric 
cancer is detected in 75 % of cas-
es [4–6]. Among the number of 
patients with newly diagnosed 
gastric cancer, 62.6 % did not 
live for 1 year [2, 7, 8]. Surgical 
treatment covers about 45.0– 
50.0 % of patients with a mor-
tality of 15–20 %, with low rates 
of operability and resectability – 
40.5 % and 62.1 %, respectively, 
explain the dissatisfaction with 
the results of surgical treatment 
of patients in this group of pa-
tients and the relevance this to- 
pic [3, 9, 10].
Gastrointestinal bleedings are 
one of the most serious and most 
common acute complications of 
gastric cancer and their number 
and severity is progressively in-
creasing every year [4, 5, 8–9].
The statement that the com-
plication of gastric tumor by 
bleeding is a sign of neglect and 
inoperability of the process – 
is false and with recent studies 
has undergone a radical revi- 
sion [8–10]. Progress in this di-
rection is early diagnosis, suc-
cessful minimally invasive endo-
luminal endoscopic hemostasis, 
clarification of the stage of the 
tumor process, performing in a 
significant number of patients both radical and palliative sur-
gical interventions after comprehensive training and examina-
tion [1, 6, 8–10]. Operations at the height of bleeding are rarely 
performed, only for vital indications, because they are accom-
panied by a high frequency of postoperative complications and 
mortality [1, 6]. In the surgery of gastric cancer complicated by 
bleeding, the attention of surgeons is focused not only on the 
possibility of radical removal of the tumor, but also on the use 
of new methods of gastrectomy and subtotal gastrectomy, re-
constructive esophagojejunoplasty with the formation of small 
bowel reservoirs, quality of life of such patients [6].
The aim of the work. The main purpose of this study is im-
proving the results of surgical treatment of patients with malig-
nant gastric tumors complicated 
by gastrointestinal bleeding, by 
developing and implementing in 
clinical practice a new treatment 
tactic.
2. Materials and methods
The study was conducted 
on the basis of the Kyiv City 
Center for Emergency Care of 
Patients with Gastrointestinal 
Bleeding and in the Kyiv City 
Clinical Ambulance Hospital for 
the period from 2010 to 2020. 
Criteria for inclusion in the study 
were patients who were urgently 
hospitalized and operated on in 
an urgent or delayed period for 
acute gastrointestinal bleeding, 
the source of which is a malig-
nant tumor of the stomach. The 
exclusion criteria were patients 
operated on for gastrointestinal 
bleedings of other etiologies. The 
study was agreed and approved 
at a meeting of bioethics com-
mission of O. Bogomolets Na-
tional medical university (expert 
opinion No. 121 dated 24.04.19). 
The study materials contain 
“Informed patient consent”, the 
study does not involve an in-
creased risk for study subjects 
and is performed in accordance 
with existing bioethical norms 
and scientific standards for con-
ducting clinical trials involving 
patients. And the study was con-
ducted according to basic bio-
ethical standards Helsinki Dec-
laration of the World Medical 
Association on Ethics principles 
of scientific and medical research 
as amended (2008), Universal 
Declaration of Bioethics and Hu-
man Rights (1977), Convention 
Council of Europe for Human 
Rights and Biomedicine (1997). 
During the study, we used the 
methods of statist observation, 
the method of compilation and 
grouping of primary statistical material and determining gen-
eralized summary indicators. All data, obtained during the 
study, were statistically processed using packages of software 
statistical analysis MedStat, IBM SPSS Statistics Base v.22. and 
EZR (R-statistics) by used rank correlation method – Spearman 
coefficient (p), pairwise group comparisons were performed 
using the non-parametric Wilcoxon method, methods of vari-
ational statistics, the standard deviation S, the mean error m, 
the difference at p˂0.05 was considered statistically significant. 
A comprehensive examination and retrospective analysis 
of the results of treatment of 140 patients in which gastric ma-
lignant tumors were complicated by gastrointestinal bleeding 
and which amounted to 2.2 % of all patients treated for gastro-
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Abstract: The aim is to improve the results of surgical treat-
ment of patients with gastric malignant tumors, complicated 
by gastrointestinal bleeding, by developing and implementing 
in clinical practice a new treatment tactic.
Materials and methods. The study was conducted on the 
basis of the Kyiv City Center for Emergency Care of Pa-
tients with Gastrointestinal Bleedings and at the Kyiv City 
Clinical Ambulance Hospital (Ukraine) for the period from 
2010 to 2020. A comprehensive examination and analysis of 
reatment’s results of 140 patients with malignant gastric tu-
mors complicated by acute gastrointestinal bleeding, which 
amounted to 2.2 % of all reated patients with gastrointestinal 
bleeding during this period.
Results. Radical operations were performed in 97 (69.3 %) 
patients, palliative and symptomatic – in 43 (30.7 %). Compar-
ing the frequency of complications in the two periods of treat-
ment of patients, a decrease in the second period, compared 
with the first period, the frequency of complications from 
27.2 % to 11.4 % due to a decrease of 1.8 times (from 68.8 % to 
37.5 %) complications after emergencies and related fatalities 
from 36.4 % to 0 and 2.2 times (from 20.8 % to 9.6 %) the in-
cidence of complications after early delayed operations with a 
decrease in frequency fatalities from 20.9 % to 18.2 %.
Conclusions. Operations at the height of acute bleeding in 
patients with gastric cancer are too dangerous due to the high 
postoperative mortality. The optimal standard is the use of a set 
of minimally invasive methods of endosurgical hemostasis to 
stop active bleeding and prevent its recurrence and operate on 
patients in the early delayed period. Adherence to such tactics 
is expedient from the point of view of reduction of risk for a life 
of the patient and possibility of carrying out radical operations.
Keywords: malignant tumors of the stomach, gastrointestinal 
bleeding, surgical tactics, endoscopic hemostasis, radical sur-
gery, postoperative complications, postoperative mortality.
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intestinal bleeding during this period. The age of 92 (65.7 %) 
men and 48 (34.3 %) women was from 19 to 90 years, and the 
largest number of patients was observed in the age groups 61– 
70 years – 43 (30.7 %), and 71–80 years – 34 (24.3 %) patients, 
the average age of patients was 61.5±13.1 years. The ratio of men 
to women was 2:1. The study of treatment results was performed 
in two groups of patients treated for two periods, which cor-
respond to the stages of improvement and implementation in 
clinical practice of minimally invasive methods of endosurgical 
interventions aimed at stopping active bleeding and preventing 
its recurrence, as well as revising the principles of approach and 
criteria tactics. The I period – patients who were treated in our 
clinic from 2010 to 2016 and II period – patients who were treat-
ed in our clinic from 2017 to 2020. 
In the first period, the analysis of the results of treatment of 
patients with malignant tumors of the stomach complicated by 
gastrointestinal bleeding. Based on the analysis, the criteria for 
selecting the algorithm of surgical tactics are developed. The de-
veloped algorithm of medical tactics is introduced in the II peri-
od of treatment of patients, after which the comparative analysis 
of results of patients treatment in two periods is carried out.
The structure of gastric malignancies in the two periods of 
patients treatment are presented in Table 1.
Table 1
The structure of gastric malignancies in the two periods of 
patients treatment






Malignant tumors of the 
stomach 76 64 140
Stomach cancer 60 53 113
Gastric sarcoma 16 11 27
According to the classification adopted in our clinic (Bra- 
tus V. 1988), in 68 (48.6 %) patients gastrointestinal bleeding was 
moderate, in 41 (29.3 %) – moderate and 31 (22.1 %) patients had 
severe bleeding, of which 9 (29.0 %) patients were delivered in a 
state of severe hemorrhagic shock.
The presence of gastrointestinal bleeding was established 
on the basis of clinical symptoms, as well as according to en-
doscopic examination with verification of the corresponding 
stigmata of bleeding activity according to Forrest J.A.H.: (1974). 
Thus, 27 (19.3 %) patients were hospitalized with endoscopic 
signs of ongoing bleeding (FIA, FIB), 82 (58.6 %) patients 
with unstable hemostasis (28 (34.1 %) patients with FIIB and 
54 (65.9 %) patients with FIIC) and 31 (22.1 %) patients were 
hospitalized with endoscopic signs of stable hemostasis (FIII, 
defect under fibrin).
According to the International Classification of TNM of the 
eighth revision (2016), all patients were hospitalized at different 
stages of cancer, among them the largest group were patients 
with stage III (47 patients) and IV (43 patients), with stage II 
were 32 and the smallest group was patients with initial I and Cr 
in situ stages of the oncological process (9 patients, respectively). 
Among patients with newly diagnosed gastric cancer (51), oper-
ative activity was 50.7 % (71 of 140 patients).
Treatment tactics were determined depending on the preva-
lence of tumor lesions and the stage of the process, the presence 
of concomitant pathology, the severity of blood loss, the state 
of hemostasis. Thus, in the presence of active tumor bleeding, 
patients underwent minimally invasive endosurgical interven-
tions aimed at stopping it, and in the presence of stigma of re-
cent bleeding, endosurgical hemostasis measures are indicated 
to prevent recurrence of tumor bleeding. In total, endoscopic 
hemostasis was performed in 56 (40 %) patients with signs of 
active, including recurrent, bleeding and unstable hemostasis 
after spontaneous cessation of tumor bleeding, with a high risk 
of recurrence of bleeding.
3. Results
Radical operations were performed in 97 (69.3 %) patients, 
palliative and symptomatic – in 43 (30.7 %). Radical operations 
were performed in the following stages of the tumor process: 
stage I and Cr in situ – 19 (13.6 %), II – 48 (34.3 %), III – 
45 (32.1 %), IV – 28 (20.0 %). 
As a matter of urgency, 19 (13.6 %) patients were operated on 
at the height of ongoing bleeding and at the height of its recur-
rence, with a mortality of 5.3 % (1 patient): 17 radically (89.5 %), 
including standard radical gastrectomy performed 12 (70.6 %) 
patients, gastrectomy – 5 (29.4 %), non-radical surgery – 2 (10.5 %) 
patients who performed stitching of bleeding vessels of the stom-
ach. 121 (86.4 %) patients underwent surgery for acute gastric ma- 
lignancy in the early delayed period, after adequate preoperative 
preparation and comprehensive follow-up, of which 80 patients 
managed to undergo radical surgery. Among them – 55 (68.8 %) 
standard radical resections of the stomach, 25 (68.8 %) – radical 
gastrectomies, among which 5 (20 %) – advanced radical gastrec-
tomies with spelenectomy and resection of the tail of the pan-
creas (as a consequence of tumor growth in neighboring organs 
and tissues) and 12 (48 %) patients underwent surgery aimed at 
improving the quality of life of patients in the postoperative pe- 
riod – gastrectomy in combination with gastroenteroplasty.
In the early delayed period, palliative and symptomatic 
operations were performed in 41 (29.3 %) patients: palliative 
gastrectomy – 32 (78.0 %); imposition of gastroenteroanasto-
mosis – 5 (12.2 %): posterior anterolateral on a short loop – 
2 (4.9 %), anterior anterolateral on a long loop with Brownian 
conjunctiva – 2 (4.9 %). Palliative surgery was supplemented by 
alcoholization of liver metastases in 9 (22 %) patients and peri-
toneal fenestration – in 2 (4.9 %).
The total postoperative mortality was 7.1 % (10 patients), 
6 (4.3 %) patients died after radical surgery, and 4 (2.9 %) after 
palliative and symptomatic surgery (for all types of operations, 
statistically significant differences in the distribution of indica-
tors did not differ from normal at the level of significance (p≥0.1).
Five-year survival after radical surgery was 44.5 % and 
10-year survival was 8.9 %, with a median life of 29 months. 
After 97 radical surgical interventions, the development 
of 57 complications was noted in 20 (20.6 %) patients. Surgical 
complications (42) occurred in 16 (64.5 %) patients, non-surgi-
cal complications (15) were noted in 4 (4.1 %) patients. 
In 43 patients who underwent non-radical operations, 17 com-
plications were noted, which developed in 12 (27.9 %) patients. 
The surgical group of complications (11) was identified in 
5 (11.6 %) cases, the non-surgical group (6) in 7 (16.3 %) cases. 
4. Discussion 
When comparing the frequency of complications, it was 
found that after radical operations, surgical complications 
were 4 times more common than non-surgical complications, 
(p˂0.05). In the group of patients who underwent non-radical 
operations in the vast majority of cases there were complications 
not related to surgery – 7 (16.3 %), and complications whose 
development is associated with surgical treatment were noted in 
5 (11.6 %) cases (p˂0.05). 
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Complications after radical surgery caused 6 (4.3 %) deaths, 
after non-radical operations complications led to 4 (2.9 %) deaths.
Analysis of the types of complications that caused fatal 
consequences, found that after radical surgery, 2.8 times more 
common complications associated with surgical treatment, in 
contrast to patients who underwent non-radical surgery, where 
among the complications that caused death, in 2.7 times are 
those that are not associated with surgical treatment (p˂0.05).
Comparing the frequency of complications in the two pe-
riods of treatment patients, a decrease in the second period, 
compared with the first period, the frequency of complications 
from 27.2 % to 11.4 % due to a decrease of 1.8 times 37.5 %) com-
plications after emergencies and related fatalities from 36.4 % to 
0 and 2.2 times (from 20.8 % to 9.6 %) the incidence of complica-
tions after early delayed operations with a decrease the frequen-
cy of fatalities from 20.9 % to 18.2 %, the obtained differences 
are statistically significant at the level of significance, p≤0.05.
The mortality rate after complications that developed after 
emergency operations was consistently high and was 100 % in 
two periods of treatment, due to the conduct of patients in the 
IV clinical group “despair operations” to stop profuse tumor 
bleeding on the background of generalization of malignant tu-
mors and multiorgan insufficiency due to cancer intoxication, 
this is also confirmed by the study of Skierucha M et al., where 
100 % mortality was obtained after complications that devel-
oped after emergency surgery too [7].
Mortality after complications that developed after early- 
delayed operations decreased from 53.8 % in the first period 
to 40.0 % in the second period (p˂0.05). The mortality rate 
obtained in the second period of our study is 1.5 times lower 
than the mortality rate obtained in the study by Lazyrsky V. 
(60 %) and 1.7 times lower than the mortality shown by Lin- 
hua Yao et al (68 %), [4, 9].
Study limitations were the lack of documented histo-
pathological findings in urgently operated patients who had 
been previously diagnosed with cancer and who died without 
autopsy and patients who did not require a complete package of 
laboratory tests. 
Prospects for further research on this issue are the devel-
opment of new treatment and tactical approaches to improve the 
treatment of patients with acute complications of gastric ma-
lignancies, based on minimally invasive endoscopic measures 
of hemostasis, clinical and endoscopic monitoring to prevent 
recurrence of bleeding. surgical intervention, the choice of 
method and timing of its implementation.
5. Conclusions
Mortality after emergency operations at the height of ongo-
ing and recurrent bleeding is 4.6 times higher than after oper-
ations performed in the early delayed period, performed after 
adequate preparation and comprehensive follow-up of patients, 
with the proportion of deaths after radical surgery is 2.1 times 
less in comparison with palliative and symptomatic operations. 
Therefore, we consider operations at the height of bleeding in 
patients with acute gastric cancer to be too dangerous, which is 
associated with high postoperative mortality.
The optimal standard is the use of a set of minimally 
invasive methods of endosurgical hemostasis to stop active 
bleeding and prevent its recurrence and operate on patients 
in the early delayed period. Adherence to this tactic is appro-
priate in terms of reducing the risk to the patient’s life and 
the possibility of radical surgery with lymph dissection in the 
volume of D2.
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